On April 22, 2024, John M. Siebert, Ph.D. informed Supernus Pharmaceuticals, Inc. that he has decided to retire from the Company's Board of Directors (the "Board"), effective at the Company's Annual Meeting of Stockholders in June 2024, and therefore is not standing for re-election at the Annual Meeting. He indicated that his decision is not the result of any disagreement with the Company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.11 USD | -1.45% | -3.42% | -6.39% |
May. 23 | Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study | MT |
May. 23 | Transcript : Supernus Pharmaceuticals, Inc. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.39% | 1.51B | |
+16.34% | 79.03B | |
+8.65% | 8.78B | |
-16.33% | 4.83B | |
+51.22% | 4.65B | |
+2.18% | 3.89B | |
+20.51% | 2.34B | |
-26.79% | 2.18B | |
+15.12% | 2.11B | |
-36.56% | 2B |
- Stock Market
- Equities
- SUPN Stock
- News Supernus Pharmaceuticals, Inc.
- Supernus Pharmaceuticals, Inc. Announces Retirement of John M. Siebert from the Board of Directors